US2019285657A1PendingUtilityA1
Method of selecting antioxidants for use in topically applied compositions
Est. expiryJan 25, 2028(~1.5 yrs left)· nominal 20-yr term from priority
A61P 39/06A61P 17/16A61P 17/02A61P 17/00A61K 8/9789A61K 8/9794G01N 33/92A61K 49/00A61K 8/678A61K 8/37C12Q 1/025A61K 2800/522A61Q 17/04G01N 33/502G01N 33/5082G01N 33/5088A61K 8/97
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Antioxidant-containing compositions and methods for confirming antioxidant activity of a composition formulated for topical application to skin. Methods for testing a composition for ability to inhibit both ultraviolet radiation-induced lipid peroxidation on skin and ultraviolet radiation-induced reactive oxygen species formation in the stratum corneum. Compositions and methods for treating and preventing photodamage to skin.
Claims
exact text as granted — not AI-modified1 - 2 . (canceled)
3 . A composition for topical application, wherein the composition comprises at least one antioxidant compound that substantially inhibits ultraviolet radiation-induced reactive oxygen species formation in the upper layers of the epidermis and at least one antioxidant compound that substantially inhibits ultraviolet radiation-induced reactive oxygen species formation in the lower layers of the epidermis.
4 . The composition of claim 3 , which comprises Vitamin E in an amount of about 0.25% by weight.
5 . The composition of claim 3 , which comprises Vitamin E in an amount of about 0.5% by weight.
6 . The composition of claim 3 , which comprises diethylhexyl syringylidene malonate.
7 . The composition of claim 4 , which further comprises diethylhexyl syringylidene malonate.
8 . The composition of claim 5 , which further comprises diethylhexyl syringylidene malonate.
9 . The composition of claim 3 , which further comprises at least one sunscreen active agent.
10 . The composition of claim 9 , wherein the sunscreen active agent is chosen from the group consisting of para aminobenzoic acid, avobenzone, cinoxate, dioxybenzone, homosalate, menthyl anthranilate, octyl salicylate, oxybenzone, padimate O, phenylbenzimidazole sulfonic acid, sulisobenzone, trolamine salicylate, titanium dioxide, zinc oxide, diethanolamine methoxycinnamate, digalloy trioleate, ethyl dihydroxypropyl PABA, glyceryl aminobenzoate, lawsone with dihydroxyacetone, red petrolatum, ethylhexyl triazone, dioctyl butamido triazone, benzylidene malonate polysiloxane, terephthalylidene dicamphor sulfonic acid, disodium phenyl dibenzimidazole tetrasulfonate, diethylamino hydroxybenzoyl hexyl benzoate, bis diethylamino hydroxybenzoyl benzoate, bis benzoxazoylphenyl ethylhexylimino triazine, drometrizole trisiloxane, methylene bis-benzotriazolyl tetramethylbutylphenol, bis-ethylhexyloxyphenol methoxyphenyltriazine, 4-methylbenzylidenecamphor, isopentyl 4-methoxycinnamate, and mixtures thereof.Join the waitlist — get patent alerts
Track US2019285657A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.